Phase II trial of dose intensification with cisplatin and carboplatin plus vindesine in patients with inoperable non-small cell lung cancer

Yoichi Nakanishi, Koichi Takayama, Masayuki Kawasaki, Jun Yatsunami, Satoru Inutsuka, Kentaro Wakamatsu, Nobuko Tsuruta, Nobuyuki Hara

Research output: Contribution to journalArticlepeer-review

5 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Phase II trial of dose intensification with cisplatin and carboplatin plus vindesine in patients with inoperable non-small cell lung cancer'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science